Relationship of serum brain-derived neurotrophic factor level with other markers of disease severity in patients with atopic dermatitis

Clinical Immunology

Volumn 122, Issue 2, 2007, Pages 181-186

  Namura, Kenji ^a   Hasegawa, Goji ^b   Egawa, Masato ^a   Matsumoto, Tadasu ^a   Kobayashi, Rina ^a   Yano, Tadashi ^a   Katoh, Norito ^c   Kishimoto, Saburo ^c   Ohta, Mitsuhiro ^d   Obayashi, Hiroshi ^e   Ose, Hiroyuki ^b   Fukui, Michiaki ^b   Nakamura, Naoto ^b   Yoshikawa, Toshikazu ^b  

^a MEIJI UNIVERSITY OF INTEGRATIVE MEDICINE   (Japan)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c Graduate School of Medical Science   (Japan)

^d KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^e Institute of Bio Response Informatics   (Japan)

Author keywords

Atopic dermatitis; Brain derived neurotrophic factor; Eosinophils; Th1 Th2 cells

Indexed keywords

BIOCHEMICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR;

ADULT; ARTICLE; ATOPIC DERMATITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; EOSINOPHIL COUNT; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REMISSION; TH2 CELL;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DERMATITIS, ATOPIC; EOSINOPHILS; FEMALE; HUMANS; MALE; NERVE GROWTH FACTOR; SEVERITY OF ILLNESS INDEX; TH2 CELLS;

EID: 33846083815     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.10.011     Document Type: Article

References (42)

1. Hanifin J.M., and Rajka G. Diagnostic features of atopic dermatitis. Acta Derm.-Venereol. (Stock.) 92 (1980) S44-S47 (Supplement)
2. Leung D.Y. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J. Allergy Clin. Immunol. 105 (2000) 860-876
3. Sprgel J.M., and Paller A.S. Atopic dermatitis and the atopic march. J. Allergy Clin. Immunol. 112 (2003) S118-S127 (Supplement)
4. Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., and Hamid Q.A. New insights into atopic dermatitis. J. Clin. Invest. 113 (2004) 651-657
5. Cookson W.O., and Moffatt M.F. The genetics of atopic dermatitis. Curr. Opin. Allergy Clin. Immunol. 2 (2002) 383-387
6. Novac N., Bieber T., and Leung D.Y. Immune mechanisms leading to atopic dermatitis. J. Allergy Clin. Immunol. 112 (2003) S128-S139 (Supplement)
7. Cookson W.O., Ubhi B., Lawrence R., Abecasis G.R., Walley A.J., Cox H.E., Coleman R., Leaves N.J., Trembath R.C., Moffatt M.F., and Harper J.I. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat. Genet. 27 (2001) 372-373
8. Farrell A.M., Antrobus P., Simpson D., Powell S., Chapel H.M., and Ferry B.L. A rapid flow cytometric assay to detect CD4+ and CD8+ T-helper (Th) 0, Th1 and Th2 cells in whole blood and its application to study cytokine levels in atopic dermatitis before and after cyclosporin therapy. Br. J. Dermatol. 144 (2001) 24-33
9. La Grutta S., Richiusa P., Pizzolanti G., Mattina A., Pajno G.B., Citarrella R., Passalacqua G., and Giordano C. CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. Allergy 60 (2005) 391-395
10. Yamashita N., Kaneko S., Kouro O., Furue M., Yamamoto S., and Sakane T. Soluble E-selectin as a marker of disease activity in atopic dermatitis. J. Allergy Clin. Immunol. 99 (1997) 410-416
11. Czech W., Krutmann J., Schopf E., and Kapp A. Serum eosinophil cationic protein (ECP) is a sensitive measure for disease activity in atopic dermatitis. Br. J. Dermatol. 126 (1992) 351-355
12. Furue M., Sugiyama H., Tsukamoto K., Ohtake N., and Tamaki K. Serum soluble IL-2 receptor (sIL-2R) and eosinophil cationic protein (ECP) levels in atopic dermatitis. J. Dermatol. Sci. 7 (1994) 89-95
13. Wolkerstorfer A., MLaan M.P., Savelkoul H.F., Neijens H.J., Mulder P.G., Oudesluys-Murphy A.M., Sukhai R.N., and Oranje A.P. Soluble E-selectin, other markers of inflammation and disease severity in children with atopic dermatitis. Br. J. Dermatol. 138 (1998) 431-435
14. Gebhardt M., Wenzel H.C., Hipler U.C., Herrmann D., and Wollina U. Monitoring of serologic immune parameters in inflammatory skin diseases. Allergy 52 (1997) 1087-1094
15. Leibrock J., Lottspeich F., Hohn A., Hofer M., Hengerer B., Masiakowski P., Thoenen H., and Barde Y.A. Molecular cloning and expression of brain-derived neurotrophic factor. Nature 341 (1989) 149-152
16. Hofer M., Pagliusi S.R., Hohn A., Leibrock J., and Barde Y.A. Regional distribution of brain-derived neurotrophic factor mRNA in the adult mouse brain. EMBO J. 9 (1990) 2459-2464
17. Hohn A., Leibrock J., Bailey K., and Barde Y.A. Identification and characterization of a novel member of the nerve growth factor/brain-derived neurotrophic factor family. Nature 344 (1990) 339-341
18. Kolbeck R., Jungbluth S., and Barde Y.A. Characterisation of neurotrophin dimers and monomers. Eur. J. Biochem. 225 (1994) 995-1003
19. Barde Y.A. The nerve growth factor family. Prog. Growth Factor Res. 2 (1990) 237-248
20. Sobue G., Yamamoto M., Doyu M., Li M., Yasuda T., and Mitsuma T. Expression of mRNAs for neurotrophins (NGF, BDNF, and NT-3) and their receptors (p75NGFR, trk, trkB, and trkC) in human peripheral neuropathies. Neurochem. Res. 23 (1998) 821-829
21. Tucker K.L., Meyer M., and Barde Y.A. Neurotrophins are required for nerve growth during development. Nat. Neurosci. 4 (2001) 29-37
22. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24 (2001) 677-736
23. Vega J.A., Garcia-Suarez O., Hannestad J., Perez-Perez M., and Germana A. Neurotrophins and the immune system. J. Anat. 203 (2003) 1-9
24. Nocker W.A., and Renz H. Neurotrophins in allergic diseases: from neuronal growth factors to intercellular signaling molecules. J. Allergy Clin. Immunol. 117 (2006) 583-589
25. Bonini S., Lambiase A., Bonini S., Angelucci F., Magrini L., and Aloe L. Circulating nerve growth factor levels are increased in humans with allergic diseases and asthma. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10955-10960
26. Noga O., Hanf G., Schäper C., O'Connor A., and Kunkel G. The influence of inhalative corticosteroids on circulating Nerve Growth Factor, Brain-derived Neurotrophic Factor and Neurotrophin-3 in allergic asthmatics. Clin. Exp. Allergy 31 (2001) 196-1912
27. Toyoda M., Nakamura M., Makino T., Hino T., Kagoura M., and Morohashi M. Nerve growth factor and substance P are useful plasma markers of disease activity in atopic dermatitis. Br. J. Dermatol. 147 (2002) 71-79
28. Raap U., Goltz C., Deneka N., Bruder M., Renz H., Kapp A., and Wedi B. Brain-derived neurotrophic factor is increased in atopic dermatitis and modulates eosinophil functions compared with that seen in nonatopic subjects. J. Allergy Clin. Immunol. 115 (2006) 1268-1275
29. Lommatzsch M., Schloetcke K., Klotz J., Schuhbaeck K., Zingler D., Zingler C., Schulte-Herbrüggen O., Gill H., Schuff-Werne P., and Virchow J.C. Brain-derived neurotrophic factor in platelets and airflow limitation in asthma. Am. J. Respir. Crit. Care Med. 171 (2005) 115-120
30. Kunz B., Oranje A.P., Labreze L., Stalder J.F., Ring T., and Taieb A. Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis. Dermatology 195 (1997) 10-19
31. Leon A., Buriani A., Dal Toso R., Fabris M., Romanello S., Aloe L., and Levi-Montalcini R. Mast cells synthesize, store, and release nerve growth factor. Proc. Natl. Acad. Sci. U. S. A. 91 (1994) 3739-3743
32. Tam S.Y., Tsai M., Yamaguchi M., Yano K., Butterfield J.H., and Galli S.J. Expression of functional TrkA receptor tyrosine kinase in the HMC-1 human mast cell line and in human mast cells. Blood 90 (1997) 1807-1820
33. Lambiase A., Bracci-Laudiero L., Bonini S., Bonini S., Starace G., D'Elios M., De Carli M., and Aloe L. Human CD4+ T cell clones produce and release nerve growth factor and express high-affinity nerve growth factor receptors. J. Allergy Clin. Immunol. 100 (1997) 408-414
34. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., Kolbeck R., Hoppe E., Oropeza-Wekerle R.L., Bartke I., Stadelmann C., Lassmann H., Wekerle H., and Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J. Exp. Med. 189 (1999) 865-870
35. Torcia M., Bracci-Laudiero L., Lucibello M., Nencioni L., Labardi D., Rubartelli A., Cozzolino F., Aloe L., and Garaci E. Nerve growth factor is an autocrine survival factor for memory B lymphocytes. Cell 85 (1996) 345-356
36. Hammarberg H., Risling M., Hokfelt T., Cullheim S., and Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 20 (2000) 5283-5291
37. Toyoda M., Nakamura M., Makino T., and Morohashi M. Localization and content of nerve growth factor in peripheral blood eosinophils of atopic dermatitis patients. Clin. Exp. Allergy 33 (2003) 950-955
38. Labouyrie E., Dubus P., Groppi A., Mahon F.X., Ferrer J., Parrens M., Reiffers J., de Mascarel A., and Merlio J.P. Expression of neurotrophins and their receptors in human bone marrow. Am. J. Pathol. 154 (1999) 405-415
39. Ehrhard P.B., Ganter U., Stalder A., Bauer J., and Otten U. Expression of nerve growth factor and nerve growth factor receptor tyrosine kinase Trk in activated CD4-positive T-cell clones. Proc. Natl. Acad. Sci. U. S. A. 90 (1993) 10984-109888
40. Noga O., Englmann C., Hanf G., Grutzkau A., Guhl S., and Kunkel G. Activation of the specific neurotrophin receptors TrkA, TrkB and TrkC influences the function of eosinophils. Clin. Exp. Allergy 32 (2002) 1348-1354
41. Braun A., Lommatzsch L., Mannsfeldt A., Neuhaus-Steinmetz U., Fischer A., Schnoy N., Lewin G.R., and Renz H. Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. Am. J. Respir. Cell Mol. Biol. 21 (1999) 537-546
42. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., and Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 125 (2002) 2381-2391